134 related articles for article (PubMed ID: 36008616)
1. JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.
Yoshino T; Pentheroudakis G; Mishima S; Overman MJ; Yeh KH; Baba E; Naito Y; Calvo F; Saxena A; Chen LT; Takeda M; Cervantes A; Taniguchi H; Yoshida K; Kodera Y; Kitagawa Y; Tabernero J; Burris H; Douillard JY
Ann Oncol; 2020 Jul; 31(7):861-872. PubMed ID: 32272210
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection.
Brozos-Vázquez E; Toledano-Fonseca M; Costa-Fraga N; García-Ortiz MV; Díaz-Lagares Á; Rodríguez-Ariza A; Aranda E; López-López R
Cancer Treat Rev; 2024 Apr; 125():102719. PubMed ID: 38490088
[TBL] [Abstract][Full Text] [Related]
3. Current Clinical Practice of Precision Medicine Using Comprehensive Genomic Profiling Tests in Biliary Tract Cancer in Japan.
Kanai M
Curr Oncol; 2022 Sep; 29(10):7272-7284. PubMed ID: 36290850
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023.
Heise C; Nieto AE; Scheck MK; Ekmekciu I; Sommerhäuser G; Reinacher-Schick A; Hofheinz RD; Lorenzen S; Wege H; Kunzmann V; Götze TO; Mavroeidi IA
Oncol Res Treat; 2024; 47(5):233-237. PubMed ID: 38387453
[No Abstract] [Full Text] [Related]
5. Bile liquid biopsy in biliary tract cancer.
Liu F; Hao X; Liu B; Liu S; Yuan Y
Clin Chim Acta; 2023 Nov; 551():117593. PubMed ID: 37839517
[TBL] [Abstract][Full Text] [Related]
6. Tumour-Agnostic Therapy for Pancreatic Cancer and Biliary Tract Cancer.
Kato S
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33562094
[TBL] [Abstract][Full Text] [Related]
7. Molecular diagnostics of hepatobiliary and pancreatic neoplasias.
Longerich T; Stenzinger A; Schirmacher P
Virchows Arch; 2024 Feb; 484(2):263-272. PubMed ID: 38429607
[TBL] [Abstract][Full Text] [Related]
8. [Chinese expert consensus on the whole-course standardized management of biliary tract cancer(2023)].
;
Zhonghua Wai Ke Za Zhi; 2024 Jun; 62(6):504-513. PubMed ID: 38682619
[TBL] [Abstract][Full Text] [Related]
9. A combination of faecal and intratumour microbial community profiling reveals novel diagnostic and prognostic biomarkers for pancreatic tumours.
Wang W; Qian C; Wang T; Jiang Y; Zhou Y; Liu K; Ma Z; Liu P; Wu Y; Chen L; Wang H; Zhou T
Clin Transl Med; 2024 Jun; 14(6):e1726. PubMed ID: 38822473
[No Abstract] [Full Text] [Related]
10. Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Trigo J; García-Cosío M; García-Castaño A; Gomà M; Mesia-Nin R; Ruiz-Bravo E; Soria-Rivas A; Castillo P; Braña-García I; Alberola-Ferranti M
Clin Transl Oncol; 2022 Oct; 24(10):1890-1902. PubMed ID: 35739348
[TBL] [Abstract][Full Text] [Related]
11. [Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology].
Navarro S; Cuatrecasas M; Hernández-Losa J; Landolfi S; Musulén E; Ramón Y Cajal S; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; García-Alfonso P
Rev Esp Patol; 2021; 54(1):41-54. PubMed ID: 33455693
[TBL] [Abstract][Full Text] [Related]
12. Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: A Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Pérez JMT; García-Cosío M; García-Castaño A; Gomà M; Mesia-Nin R; Ruiz-Bravo E; Soria-Rivas A; Castillo P; Braña-García I; Alberola-Ferranti M
Rev Esp Patol; 2023; 56(1):45-57. PubMed ID: 36599600
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
García-Alfonso P; Salazar R; García-Foncillas J; Musulén E; García-Carbonero R; Payá A; Pérez-Segura P; Ramón y Cajal S; Navarro S; ;
Clin Transl Oncol; 2012 Oct; 14(10):726-39. PubMed ID: 22855150
[TBL] [Abstract][Full Text] [Related]
14. Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer.
Vera R; Ibarrola-de-Andrés C; Adeva J; Pérez-Rojas J; García-Alfonso P; Rodríguez-Gil Y; Macarulla T; Serrano-Piñol T; Mondéjar R; Madrigal-Rubiales B
Clin Transl Oncol; 2022 Nov; 24(11):2107-2119. PubMed ID: 36008616
[TBL] [Abstract][Full Text] [Related]
15. Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer.
Vera R; Ibarrola-de Andrés C; Adeva J; Pérez-Rojas J; García-Alfonso P; Rodríguez-Gil Y; Macarulla T; Serrano-Piñol T; Mondéjar R; Madrigal-Rubiales B
Rev Esp Patol; 2023; 56(1):32-44. PubMed ID: 36599598
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]